NCT07456345

Brief Summary

The purpose of this study is to assess the acceptability and feasibility of including a pelvic floor muscle exercise program into the care provided to patients undergoing prostate enucleation, studying both patients and clinicians perpsectives. A second part of the study will be to compare two groups, one receiving pelvic floor muscle exercise before surgery and and the other receiving the standard treatment, which is surgery. We will evaluate patients' perceptions of integrating physiotherapy sessions before surgery and attempt to identify facilitators and barriers to pelvic floor muscle exercise among both patients and clinicians.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Apr 2024

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 29, 2024

Completed
1.6 years until next milestone

First Submitted

Initial submission to the registry

November 17, 2025

Completed
4 months until next milestone

First Posted

Study publicly available on registry

March 6, 2026

Completed
26 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2026

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2026

Completed
Last Updated

March 12, 2026

Status Verified

March 1, 2026

Enrollment Period

1.9 years

First QC Date

November 17, 2025

Last Update Submit

March 11, 2026

Conditions

Keywords

BPHHoLEPUrinary incontinencePelvic Floor Muscle Exercise

Outcome Measures

Primary Outcomes (2)

  • Patient Acceptability of the Perineal Physiotherapy Program as Measured by Patient Acceptability of a Postoperative Pelvic Floor Physiotherapy Program After Endoscopic Prostate Enucleation Questionnaire (PPP-EEP) and Percentage of Session Attendance

    Patient Acceptability of a Postoperative Pelvic Floor Physiotherapy Program After Endoscopic Prostate Enucleation Questionnaire (PPP-EEP). A majority (\>50%) of patients should agree with the 6 items on the questionnaire (score \>3/5 on the Likert scale, as lowest score is 1 = strongly disagree to highest score being 5 = strongly agree, for a total score range of 6 to 30. Higher score meaning better outcome). Attendance of ≥60% at physiotherapy sessions will be considered acceptable.

    From enrollment to 3-5 months after surgery

  • Clinician-Reported Feasibility of a Preoperative Pelvic Floor Physiotherapy Program (Urologists and Physiotherapists) Assessed by the Program Integration and Perceived Continence Benefit Questionnaire

    Program Integration and Perceived Continence Benefit Questionnaire. A majority (\>50%) of clinicians are expected to agree with the 6 questionnaire items (\>3/5 on the Likert scale, as lowest score is 1 = strongly disagree to highest score being 5 = strongly agree, for a total score range of 6 to 30. Higher score meaning better outcome.) At least 60% of preoperative pelvic floor physiotherapy (PPP) sessions will be delivered to participants prior to surgery.

    From enrollment to 3-5 months after surgery

Other Outcomes (7)

  • Evaluation of patient satisfaction regarding urinary voiding and storage symptoms assessed by the International Prostate Symptom Score (IPSS) questionnaire

    From enrollment to 3-5 months after surgery

  • Clinical changes between the preoperative and postoperative periods for each patient assessed by PSA dosage in ng/mL

    From enrollment to 3-5 months after surgery

  • Evaluation of urinary incontinence assessed by a miction diary done on 3 days and number of incontinence pads used per day

    From enrollment to 3-5 months after surgery

  • +4 more other outcomes

Study Arms (2)

Standard of care

NO INTERVENTION

No intervention, standard of care administrated.

Intervention - Pelvic Floor Muscle Exercise

EXPERIMENTAL

Three sessions of 30 minutes will be scheduled (2 before the surgery and one after the surgery) with a specialized pelvic rehabilitation physiotherapist. Teaching pelvic floor physiotherapy exercises.

Other: Pelvic Floor Muscle Exercise before and after surgery

Interventions

Teaching pelvic floor physiotherapy exercises: * Theoretical part. * Practical part, including various modalities: Manual method, where the therapist inserts a finger or a probe into the rectum to apply resistance to the muscle while asking the patient to contract and then relax the pelvic floor. Hypopressive abdominals, which involve breathing exercises to strengthen the deep abdominal muscles and support internal organs. Biofeedback, which allows the patient to visualize real-time muscle contractions. Teaching through biofeedback enables a better assessment of pelvic floor muscle endurance and contraction quality, respiratory coordination, and correction of incorrect physical postures. All patients will be provided with illustrated instructions to continue the exercises on their own.

Intervention - Pelvic Floor Muscle Exercise

Eligibility Criteria

Age18 Years+
Sexmale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with symptomatic BPH who are candidates for prostate enucleation, including: urinary retention, post-renal AKI, refractory hematuria, recurrent UTIs, symptoms refractory to medical therapies, IPSS \> 8, urinary flow rate \< 15 mL/sec.
  • Patients able to perform pelvic floor physiotherapy exercises independently.
  • Patients who agree to additional outpatient physiotherapy visits.
  • Patients who provide consent to participate in the study.

You may not qualify if:

  • Patients with severe central or peripheral neurological diseases and gait disorders
  • Patients with a history of prostate or bladder cancer, prior prostate surgery, neurogenic bladder, or urethral stricture
  • Patients with bladder atony
  • Patients unable to continue pelvic floor muscle training independently

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centre Hospitalier de l'Université de Montréal

Montreal, Quebec, H2X 0A9, Canada

Location

Related Publications (10)

  • Park JJ, Kwon A, Park JY, Shim SR, Kim JH. Efficacy of Pelvic Floor Exercise for Post-prostatectomy Incontinence: Systematic Review and Meta-analysis. Urology. 2022 Oct;168:175-182. doi: 10.1016/j.urology.2022.04.023. Epub 2022 May 5.

  • Chang JI, Lam V, Patel MI. Preoperative Pelvic Floor Muscle Exercise and Postprostatectomy Incontinence: A Systematic Review and Meta-analysis. Eur Urol. 2016 Mar;69(3):460-7. doi: 10.1016/j.eururo.2015.11.004. Epub 2015 Nov 21.

  • Nam JK, Kim HW, Lee DH, Han JY, Lee JZ, Park SW. Risk Factors for Transient Urinary Incontinence after Holmium Laser Enucleation of the Prostate. World J Mens Health. 2015 Aug;33(2):88-94. doi: 10.5534/wjmh.2015.33.2.88. Epub 2015 Aug 19.

  • Cho MC, Park JH, Jeong MS, Yi JS, Ku JH, Oh SJ, Kim SW, Paick JS. Predictor of de novo urinary incontinence following holmium laser enucleation of the prostate. Neurourol Urodyn. 2011 Sep;30(7):1343-9. doi: 10.1002/nau.21050. Epub 2011 Apr 28.

  • Anan G, Kaiho Y, Iwamura H, Ito J, Kohada Y, Mikami J, Sato M. Preoperative pelvic floor muscle exercise for early continence after holmium laser enucleation of the prostate: a randomized controlled study. BMC Urol. 2020 Jan 23;20(1):3. doi: 10.1186/s12894-019-0570-5.

  • Houssin V, Olivier J, Brenier M, Pierache A, Laniado M, Mouton M, Theveniaud PE, Baumert H, Mallet R, Marquette T, Villers A, Robert G, Rizk J. Predictive factors of urinary incontinence after holmium laser enucleation of the prostate: a multicentric evaluation. World J Urol. 2021 Jan;39(1):143-148. doi: 10.1007/s00345-020-03169-0. Epub 2020 Mar 26.

  • Elmansy HM, Kotb A, Elhilali MM. Holmium laser enucleation of the prostate: long-term durability of clinical outcomes and complication rates during 10 years of followup. J Urol. 2011 Nov;186(5):1972-6. doi: 10.1016/j.juro.2011.06.065. Epub 2011 Sep 23.

  • Bozzini G, Berti L, Aydogan TB, Maltagliati M, Roche JB, Bove P, Besana U, Calori A, Pastore AL, Muller A, Micali S, Sighinolfi MC, Rocco B, Buizza C. A prospective multicenter randomized comparison between Holmium Laser Enucleation of the Prostate (HoLEP) and Thulium Laser Enucleation of the Prostate (ThuLEP). World J Urol. 2021 Jul;39(7):2375-2382. doi: 10.1007/s00345-020-03468-6. Epub 2020 Sep 30.

  • Elterman D, Aube-Peterkin M, Evans H, Elmansy H, Meskawi M, Zorn KC, Bhojani N. UPDATE - Canadian Urological Association guideline: Male lower urinary tract symptoms/benign prostatic hyperplasia. Can Urol Assoc J. 2022 Aug;16(8):245-256. doi: 10.5489/cuaj.7906. No abstract available.

  • Lerner LB, McVary KT, Barry MJ, Bixler BR, Dahm P, Das AK, Gandhi MC, Kaplan SA, Kohler TS, Martin L, Parsons JK, Roehrborn CG, Stoffel JT, Welliver C, Wilt TJ. Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA GUIDELINE PART II-Surgical Evaluation and Treatment. J Urol. 2021 Oct;206(4):818-826. doi: 10.1097/JU.0000000000002184. Epub 2021 Aug 13.

MeSH Terms

Conditions

Prostatic HyperplasiaUrinary Incontinence

Interventions

Postoperative Period

Condition Hierarchy (Ancestors)

Prostatic DiseasesGenital Diseases, MaleGenital DiseasesUrogenital DiseasesMale Urogenital DiseasesUrination DisordersUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsLower Urinary Tract SymptomsUrological ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Perioperative PeriodSurgical Procedures, OperativePatient CareHealth ServicesHealth Care Facilities Workforce and Services

Study Officials

  • Naeem Bohjani, MD

    Centre de Recherche du Centre Hospitalier de l'Université de Montréal

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 17, 2025

First Posted

March 6, 2026

Study Start

April 29, 2024

Primary Completion

April 1, 2026

Study Completion

May 1, 2026

Last Updated

March 12, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Locations